Description of the disease Lennox-Gastaut syndrome is a dubious disease in the field of the nervous system, clinical performance is complex and often involves multi-systematic burden. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathology.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Treatment plans for the treatment and management of Lennox-Gastaut syndrome require individual characteristics, typically including multidimensional management of pharmacotherapy, rehabilitation interventions, and regular follow-up. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological disorders that have previously been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Lennox-Gastaut syndrome. The platform serves a team of experts at home and abroad in the field of China's international medical services system for matching the nervous system, providing the following services to patients: 1.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.